AHR and melanoma: We demonstrated that the Aryl hydrocarbon Receptor (AhR) transcription factor is constitutively activated in a subset of melanoma cells, promoting the dedifferentiation of melanoma cells and the expression of BRAFi‐resistant genes (Corre et al, 2018).